Dr. Timothy J. Poterucha, MD
Claim this profileMore about Timothy J. Poterucha, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Timothy J. Poterucha, MD has experience with
- Cardiac Amyloidosis Deep Learning Model
Breakdown of trials Timothy J. Poterucha, MD has run
Amyloid Polyneuropathy
Cardiac Amyloidosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Timothy J. Poterucha, MD specialize in?
Timothy J. Poterucha, MD focuses on Amyloid Polyneuropathy and Cardiac Amyloidosis. In particular, much of their work with Amyloid Polyneuropathy has involved treating patients, or patients who are undergoing treatment.
Is Timothy J. Poterucha, MD currently recruiting for clinical trials?
No, Timothy J. Poterucha, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Timothy J. Poterucha, MD has studied deeply?
Yes, Timothy J. Poterucha, MD has studied treatments such as Cardiac amyloidosis deep learning model.
What is the best way to schedule an appointment with Timothy J. Poterucha, MD?
Apply for one of the trials that Timothy J. Poterucha, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.